Bio-Rad Laboratories Inc (NYSE:BIO)
| 116.12 Data as of May 21 |  -0.29 / -0.25%Today’s Change | 91.52 Today|||52-Week Range 127.17 | +10.54% Year-to-Date |
Latest BIO News | Press Releases
| Earnings Miss at SurModics - Analyst Blog May 08 / Zacks.com | Bio-Rad Laboratories Whiffs on Earnings May 08 / MotleyFool.com |
Today’s Trading
| Previous close | 116.41 |
| Today’s open | 116.13 |
| Day’s range | -- - -- |
| Volume | 94,512 |
| Average volume (3 months) | 86,779 |
| Market cap | $2.7B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -8.63% |
| Earnings growth (this year) | -17.05% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | -0.21% |
| P/E ratio | 21.9 |
| Price/Sales | 1.44 |
| Price/Book | 1.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FEICFEI Co | -0.02 | -0.03% |
| BRKRBruker Corp | +0.60 | +3.58% |
| CPHDCepheid | +0.26 | +0.67% |
| PKIPerkinElmer Inc | +0.31 | +0.96% |
Data as of 4:04pm ET, 05/21/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | $1.29 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $163.8M |
| Net profit margin | 7.91% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Norman D. Schwartz |
CFO, Executive VP & Head-Investor Relations Christine A. Tsingos, MBA |
Corporate headquarters Hercules, California |
Forecasts
